Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019
Clinical trial NCT04310228 · UNKNOWN
Trial details
- NCT number
- NCT04310228
- Sponsor
- Peking University First Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-08
- Primary completion
- 2020-05-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.